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Toxin A of Clastr~dium d~~cile has been purified and monospecific antiserum produced. A reliable proce- 
dure for isolation and restriction of C. dl~ci~e chromosomal DNA was developed which allowed for the 
construction of a genomic library in d gtll. Approx. 35 000 plaques were screened using anti-toxin A which 
resulted in the identification of one stable positive clone, d cd19. Verification of the immunological identity 
of the isolated toxin A gene fragment in A cdl9 was determined by affinity purifying toxin A antibodies 
specific for 1 cdl9 gene product, and using these selected antibodies to probe a Western blot of purified 
toxin A. The insert in 1 cdl9 was demonstrated to be a 0.3 kb fragment by restriction digestion, and by 
hybridization of the clone to a chromosomal digest of C. d@cile. The peptide coded for by the toxin A 
gene fragment in 1 cdl9 was not cytotoxic for 3T3 mammalian tissue culture cells. 
Enterotoxin; Antibiotic-associated colitis; 1 gtll; DNA cloning 
1. INTRODUCTION 
Clostridium difficiie is a toxin-producing strict 
anaerobic bacterium which is the causative agent 
for the diarrhea1 syndrome termed antibiotic 
associated pseudomembranous colitis [1,2]. 
Evidence exists which suggests that the pathogenic 
and cytotoxigenic effect of C. difficile is mediated 
by two toxins, A and B [3-61. The enterotoxic ac- 
tivity of toxin A has been demonstrated to elicit a 
hemorrhagic fluid response in the rabbit intestinal 
loop assay, and causes fluid accumulation in the 
suckling mouse assay [4,5,7]. Toxins A and B have 
been shown to be cytotoxic for a variety of mam- 
malian tissue culture cells [8,9]; however, toxin B 
which increases the ratio of globular to filamen- 
tous actin [lo] is consequently more cytotoxic than 
toxin A. 
Toxin A has been purified and partially 
characterized [3,6,8]. This enterotoxin is a heat- 
labile protein which has been reported to have an 
Mr of approx. 500000 [3]; however, the subunit 
composition of the protein has not been clearly 
elucidated. Toxin A has been determined by amino 
acid analysis [6,7,11] to have a high degree of 
hydrophobic amino acids and to share some 
similarities with the composition of toxin B f6]. 
To obtain information on the structure of toxin 
A, and to study the regulation of toxin production 
in different strains of C. dif~cife, the toxin gene 
must be cloned and characterized. The initiation of 
this investigation is reported herein. We have iden- 
tified a DNA fragment of the toxin A gene of C. 
difficile using an antibody probe. 
2. MATERIALS AND METHODS 
Correspondence address: L.L. Muldrow, Biology Dept, 2.1. Purification of toxin A 
Spelman College, Atlanta, GA 30314, USA C. difflcile toxin A was purified from strain 
splashed by EIsevier Science polishers 3. V. (biomedical Division) 
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10463 (supplied by Tracy D. Wilkins, Virginia with Taql (approx. l-10 kb), EcoRI methylase 
Polytechnic Institute, Blacksburg, VA), by CL-6B treated and ligated to three different size Clal- 
DEAE-Sepharose column chromatography and EcoRI adapters (kindly provided by Ken Stover, 
acetic acid precipitation as described by Sullivan et Walter Reed Army Research Institute, 
al. [3] with modifications. Fractions collected after Washington, DC, unpublished). Excess adapters 
column chromatography that contained toxin A were removed by digestion and polyethylene glycol 
and several contaminating proteins were not fractionation [15]. After ligation into the unique 
discarded. These fractions were pooled, acetic acid EcoRI restriction site of Xgtll and packaging of 
precipitated at pH 5.5, and loaded on a 1.5 x the recombinant DNA (Packagene, Promega 
15 cm column of CL-6B DEAE-Sepharose which Biotec, Madison, WI), the library was directly 
had been equilibrated with 50 mM Tris-HCl (pH screened without amplification of the phage par- 
7.5) containing 0.05 M NaCl. The column was ticles. Toxin A antigen-producing plaques were 
washed with 100 ml of the same buffer and eluted visualized on nitrocellulose filters using a 1 : 200 
with a 200 ml linear 0.05-0.25 M NaCl gradient in dilution of E. coli-Agtll adsorbed anti-toxin A, 
50 mM Tris-HCl (pH 7.5). Toxin activity was and the Bio-Rad horseradish peroxidase-bound 
monitored by the cytotoxicity assay using 3T3 goat anti-rabbit IgG immunoblot kit (Richmond, 
mouse fibroblasts. CA). 
2.2. Anti-toxin A preparation 2.5. Antigen-selected antibodies 
Antiserum was produced in a 5 kg New Zealand 
White rabbit against formalin-treated toxin A 
utilizing the procedure of Ehrlich et al. [12]. Anti- 
toxin used for screening recombinant clones was 
adsorbed with E. coli Y 1090 and hgtl 1 to remove 
interfering antibodies. 
2.3. Isolation of chromosomal DNA 
Isolation of high-M, chromosomal DNA from 
C. difficile was accomplished by growing strain 
10463 overnight in 1 1 of brain heart infusion 
media containing 10 mg/ml lysozyme. The 
pelleted cells were washed in TSE buffer (25 mM 
Tris, 10% sucrose, 0.1 M EDTA, pH 8.0), and 
resuspended in 40 ml TSE with an increased 
EDTA concentration of 0.25 M. Next, 4 ml lyso- 
zyme (35 mg/ml) was added and incubated at 
25°C for 1 h. An equal volume of 33% SDS in 
0.25 M EDTA (pH 8) was added, mixed gently for 
5-20 s and extracted immediately with an equal 
volume of phenol/chloroform. Four additional 
phenol/chloroform extractions and one chloro- 
form/isoamyl extraction was performed followed 
by ethanol precipitation [ 131. 
Antibodies specific for the toxin-positive pep- 
tides encoded by recombinant Xgtl 1 phage par- 
ticles were affinity purified from toxin A 
antiserum using the procedure of Lyon et al. [16] 
with the following variations. Recombinant phage 
were plated at a density of approx. 6000 plaques 
per plate (150 mm diameter). Nitrocellulose filters 
were overlaid on the agar plates and incubated at 
37°C for 16 h which allowed for binding of an- 
tigens. The filters were next removed and suspend- 
ed overnight in a 1: 50 dilution of E. coli adsorbed 
toxin A antiserum. After washing the 
nitrocellulose paper twice in TTBS (O.OSOro Tween 
20, 50 mM Tris, 150 mM NaCl, pH 8.0) and once 
in 10 ml saline, specific antibodies which bound to 
the nitrocellulose filters were eluted by adding 
10 ml glycine buffer per filter (0.2 M glycine, 
0.15 M NaCl, pH 2.8) for 10 min. Next the 
nitrocellulose paper was removed from the glycine 
buffer and the pH of this selected antibody solu- 
tion was neutralized by adding 8 mg Tris per ml 
eluate. 
2.6. Electrophoresis and blotting 
2.4. Construction and screening of C. difficile 
genomic library 
Fragments of C. difficile’s toxin A gene were 
cloned and screened using the hgtl 1 expression 
system of Young and Davis [14] with the following 
alterations. C. difficile DNA was partially digested 
Non-denaturing polyacrylamide gel elec- 
trophoresis (PAGE) of toxin A was performed in 
a 5-15070 gradient slab gel at pH 8.3 [17]. Gels 
were stained with Coomassie blue R-259. Elec- 
trophoretic transfer (Western blotting) of proteins 
from polyacrylamide gels to nitrocellulose paper 
was performed as described by Towbin et al. 1181. 
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DNA was separated on a 0.8% agarose gel and 
stained with ethidium bromide [13]. Nick transla- 
tion with [cu-32P]dCTP and Southern blot 
hybridizations were performed as described in the 
nick translation and sure blot hybridization kits 
provided by Oncor (Gaithersburg, MD). 
2.7. Cytotoxicity testing 
Supernatant from C. difficiie cultures, purified 
or partially purified toxin A, and crude lysates 
from E. coli Y1090 (obtained from Promega 
Biotec) infected with recombinant Agtl 1 [13] and 
induced with isopropyl thio-B-D-galacto- 
pyranoside (IPTG) [14], were filter sterilized and 
cytotoxic activities determined using 31’3 mouse 
fibroblasts as in [19]. 
3. RESULTS AND DISCUSSION 
3.1. Isolation of toxin A and production of 
anti-toxin 
After modifying the toxin purification pro- 
cedure described by Sullivan et al. [3], the total 
yield of purified toxin A was increased by 20%. 
This was accomplished by pooling fractions from 
the first DEAE-Sepharose column that contained 
toxin A and several contaminating proteins, acetic 
acid precipitating and running these fractions twice 
on DEAE-Sepharose columns (table 1). The 
cytotoxic activity of toxin A is IOOO-foId lower 
than the activity of toxin B [3]; therefore, the 
minimal toxic dose of toxin A on 3T3 tissue culture 
cells could not be determined until after DEAE- 
Sepharose chromatography. The purity of the ac- 
tive toxin preparation was determined by 
polyacrylamide gel electrophoresis (fig. 1, lane i), 
and immunoeiectrophoresis using crude culture 
supernatant antiserum purchased from Virginia 
Pofytechnical Institute [12] (not shown). An- 
tiserum against oxin A was generated as described 
in section 2 (fig.1, lane 2). 
3.2. Cloning and characterization f toxin A 
The harsh conditions needed to lyse C. difficiie 
and the high nuclease activity associated with this 
bacterium prevented the use of standard pro- 
cedures for isolation of high-M, chromosomal 
DNA. A purification procedure has been 
developed and described in section 2 which yields 
high-&& G. diffici/e chromosomal DNA (> 50 kb) 
Table 1 
Purification of C. diffifiIe toxin A 
Stage Purification 
step 
Volume 
(ml) 
Total 
protein 
(me) 
Minimal” 
toxic dose 
(ng) 
Purifi- 
cation 
(-fold) 
Crude culture 
supernatant 
First purificationb 
CLdB DEAE 
Acetic acid 
precipitation 
Second purificationC 
CL-6B DEAE 
Acetic acid 
precipitation 
CLdB DEAE 
65 84.5 
32 5.8 36 1 
3.2 1.0 6.4 5.6 
20 8.9 8.9 1 
3.2 3.0 1.9 4.6 
3.0 0.2 1.3 6.8 
a Minimal toxic dose delineates the estimated amounts of protein/well after serial dilution 
which caused 50% of rounding of 3T3 fibroblasts 
b Purification procedure described by Sullivan et al. [3] 
’ Second purification represents isolation of toxin A from fractions in the DEAE column 
in stage 2 with 3-5 cont~inating proteins 
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Fig, 1. Purity of toxin A, and confirmation of cloned 
toxin determinants. PAGE and Western blot analysis 
were performed as described in section 2. Lanes: (1) 
PACE of 6pg purified toxin A; (2) Western blot of 
toxin A using contro1 toxin A antiserum, I : 200 dilution; 
(3) Western blot of toxin A with selected antibodies from 
hgtl1 control plaques; (4) Western blot of toxin A with 
antibodies selected from Xcdi9. 
Fig.2 Restriction digestion of hgtlX and Acdl9. Xgtll 
(lane 1) and Acdi9 (lane 3) were double digested with 
Sac1 and KJ& as described by the suppher. The band 
imm~djate~y above the 2.4 kb fragment in lane 3 
represents incompLete digestion of the 2.4 kb fragment 
and the lower migrating 1.51 kb fragment. Lane 2 
contains the Mr standard ~~~d~r~-d~gested h DNA (BRL 
252 
Inc., G~thersburg, MD). 
that can be digested with selective restriction 
~~KWS. 
A genomic library of C. di~~~~~~ DNA was con- 
structed in hgtll, Approx. 3500 plaques were 
screened for toxin A ~tigen-producing clones 
resulting in the original detection of 22 positive 
plaques. All but one of the identified positive pla- 
ques spontaneously lost the C. difficile inserts after 
plaque purification and amplification as indicated 
by immu~oi~~ically testing for toxin A cloned an- 
tigens, and by reversion from clear to blue plaques, 
hcdl9 was the only r~ombinant plaque stable 
enough to allow for consistent immun~la~cal 
verification; however, this clone reverts from clear 
to blue plaques at a frequency of 2%. Verification 
of the immunolo~cal identity of the isolated toxin 
A gene fragment in hcdl9 was determined by af- 
finity purifying toxin A antibodies specific for 
hcdl9 gene product, and using these selected an- 
tibodies to probe a Western blot of purified toxin 
A (fig.1) 
The EcoRI cloning site in Xgtll is contained 
within a 2.08 kb SacI-k”pnI fragment [14]. In the 
hybrid clone Xcdl9, this S~CI-KJXFZI fragment was 
increased in size from 2.08 to 2.40 kb, thereby 
9.42* 
4.35, 
3.Ife 
Fig.3. Southern hybridization of restriction digested 6. 
d~~~j~e chromosomal DNA with ~~-3*P~d~TP”l~beled 
Xcdl9. C. diffi&e ~hromosoma~ DNA was digested with 
TagI (lane I), HindILL (lane 2) and Psfi (lane 3). 
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demonstrating the presence of a 0.3 kb TaqI insert 
(fig.2). (N.B., the genomic library was generated 
with TaqI.) A 0.3 kb C. difficife DNA insert in 
hcdl9 was also demonstrated by hybridizing 
(cu-32P)-labeled nick-translated Acdl9 DNA to a C. 
difficile TuqI chromosomal digest (fig.3). The 
(cu-32P)-labeled cdl9 probe also hybridized to a 
4.5 kb fragment in a P&I chromosomal digestion 
of C. difficile, and a 16 kb fragment in a Hind111 
digestion (fig.3). 
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